-

Transdermal Skin Patches Market Competitive Landscape Report 2025: Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Competitive Landscape of Transdermal Skin Patches Market, Forecast by Recent Developments, Strategies, Sustainability Benchmarking, Product Analysis, Key Persons and Revenue" report has been added to ResearchAndMarkets.com's offering.

The Transdermal Skin Patches industry is expected to expand lucratively to an estimated value of US$ 10.98 Billion by 2033, from US$ 8.06 Billion in 2024. This expansion reflects a compound annual growth rate (CAGR) of 3.50% between 2025 and 2033.

The term "transdermal skin patches" describes a simple, non-invasive technique for delivering therapeutic dosages into the bloodstream over a predefined period of time. They include low electrical currents such as iontophoresis, backings, medications, membranes, adhesives, liners, chemical enhancers and permeators, and physical aids.

Depending on the skin's properties and the patch's design, they offer a constant diffusion rate. Human immunodeficiency virus (HIV), osteoporosis, migraine, Parkinson's disease, Alzheimer's disease, stroke, heart and hormone abnormalities, and restless legs syndrome can all be effectively treated with them. Therefore, one of the main drivers driving the market's growth is a notable rise in the proportion of the population afflicted by these conditions.

The US market is mostly driven by innovation in non-invasive health monitoring. Modern wearable patches have sensors, allowing for drug delivery and real-time vital sign monitoring. Through the provision of warnings for dosage modifications or adverse reactions, these technologies improve patient safety. For chronic illnesses, health monitoring patches provide convenience by reducing the need for frequent doctor visits. For instance, Abbott introduced Lingo, an adult over-the-counter (OTC) continuous glucose monitoring device, in the United States in September 2024.

For convenient monitoring, this cutting-edge gadget pairs smartphones with an adhesive skin patch that connects via Bluetooth. The Lingo system provides a non-invasive glucose monitoring option by doing away with the necessity for finger-stick blood tests. Patients looking for pleasant ways to manage their health are drawn to these non-invasive gadgets, which is why adoption rates are rising across the country.

Key Attributes:

Report Attribute Details
No. of Pages 200
Forecast Period 2024 - 2033
Estimated Market Value (USD) in 2024 $8.06 Billion
Forecasted Market Value (USD) by 2033 $10.98 Billion
Compound Annual Growth Rate 3.5%
Regions Covered Global

Companies Featured

  • Teva Pharmaceutical Industries Ltd.
  • 3M Company
  • Nitto Denko Corporation
  • Johnson & Johnson
  • Luye Pharma Group
  • Bayer
  • Novartis AG
  • Beiersdorf AG
  • Viatris Inc.
  • Abbott Laboratories
  • Hisamitsu Pharmaceutical Co., Inc.
  • LTS Lohmann Therapie-Systeme AG
  • GlaxoSmithKline plc
  • Luye Pharma Group Ltd.
  • Sparsha Pharma International Pvt. Ltd.
  • AdhexPharma
  • Teikoku Pharma USA Inc.
  • Biotts
  • Medherant Limited
  • Agile Therapeutics Inc.

Transdermal Skin Patches Market & Forecast

  • Historical Trends
  • Forecast Analysis

Market Share Analysis

Company Analysis

Overview

  • Company History and Mission
  • Business Model and Operations
  • Workforce

Key Persons

  • Executive Leadership
  • Operational Management
  • Division Leaders
  • Board Composition

Recent Development & Strategies

  • Mergers & Acquisitions
  • Partnerships
  • Investments

Sustainability Analysis

  • Renewable Energy Adoption
  • Energy-Efficient Infrastructure
  • Use of Sustainable Packaging Materials
  • Water Usage and Conservation Strategies
  • Waste Management and Circular Economy Initiatives

Product Analysis

  • Product Profile
  • Quality Standards
  • Product Pipeline
  • Product Benchmarking

Strategic Assessment: SWOT Analysis

  • Strengths
  • Weaknesses
  • Opportunities
  • Threats

Revenue Analysis

For more information about this report visit https://www.researchandmarkets.com/r/8foux7

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Growth Opportunities in Digital Logistics: Set to Exceed a Market Valuation of $85 Billion by 2030, Booming at 25% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Logistics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Digital Logistics Market will grow from USD 22.30 Billion in 2024 to USD 85.07 Billion by 2030 at a 25% CAGR. Main drivers include the exponential growth of e-commerce, which demands faster and more transparent delivery, and the increasing need for real-time supply chain oversight. Key Market Drivers...

The Global T-cell Therapy Market 2025-2030 by Therapy Type, Indication and Region - Shift Towards Allogeneic Platforms to Boost Market Accessibility - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "T-cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global T-cell Therapy Market, valued at USD 2.92 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 5.14 Billion by 2030. The market's expansion is significantly propelled by the increasing global prevalence of various cancers, continuous technological advancements in genetic engineering...

Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Molecular Cytogenetics Market, valued at USD 2.24 Billion in 2024, is projected to experience a CAGR of 8.33% to reach USD 3.62 Billion by 2030. This market's expansion is fundamentally driven by the increasing global prevalence of genetic conditions and oncological diseases, necessitating preci...
Back to Newsroom